The surge in PGI's surgical numbers — from zero to three — marks a 2025 milestone, but the shadow of GLP-1 receptor agonists looms large. Many surgeons fear bariatric surgery may "lose its shine" as patients increasingly opt for weekly injections over the operating table.
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/fhvCwa4
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment